New Statin TS Tablet 40/5/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
MFDS item code 202302813 · Approved 2023.09.25
Treatment of hyperlipidemia and hypertension, and inhibition of atherosclerotic progression and cardiovascular disease risk
This medication is prescribed to patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using a combination of telmisartan and amlodipine. Additionally, rosuvastatin calcium serves as an adjunct to the diet in patients with hypercholesterolemia and dyslipidemia, lowering blood cholesterol and LDL levels, and delaying the progression of atherosclerosis. For patients at high risk for cardiovascular diseases, it helps reduce the risk of stroke, myocardial infarction, and vascular reconstruction. Therefore, this medication is effective for the treatment of patients with both hypertension and dyslipidemia and is used to improve cardiovascular health.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). This medicine is intended for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking the telmisartan/amlodipine combination together with rosuvastatin as a single-ingredient product, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and should continue this diet throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication can cause serious harm to the fetus and newborn when taken during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Do not take if you are allergic to any of the ingredients in this medication or similar medications. It should not be administered to patients with severe impairment of liver or kidney function, certain heart diseases, or a history of angioedema. Elderly patients, those with hypotension, patients with mild liver impairment, and those with high potassium levels should take caution and may require regular monitoring. If symptoms such as muscle pain or weakness occur, consult a physician immediately, and in severe cases, discontinuation of the medication may be necessary. This medication can affect liver and kidney function, so regular blood tests and liver function tests are important. Since it may interact with other medications, inform your physician or pharmacist of any other medications you are taking. Women of childbearing potential should use appropriate contraception, and if breastfeeding, should either avoid taking this medication or discontinue breastfeeding. The safety of this medication has not been sufficiently confirmed for children; therefore, it is not recommended for patients under 18 years of age. In case of overdose, symptoms may include low blood pressure, dizziness, and renal impairment, and immediate medical attention should be sought. Store this medication out of reach of children and be cautious as transferring it to another container may compromise quality.
This medication is packed in a special package that protects it from light and air. Store the medication at room temperature between 1°C and 30°C. This will help maintain its effectiveness over time.
A round bilayer tablet composed of a white layer and a light blue layer
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.